Home Authors Posts by Sarah Pringle

Sarah Pringle

Physician-owned Allergy Partners is on the auction block, according to four sources. The company, considered the largest U.S. allergy and asthma practice group, has turned to Wells Fargo for financial advice, the sources said. Allergy Partners generates EBITDA in the low $20 million range and ought to command a double-digit multiple should the process produce […]
Northeast Dermatology Associates, one of the few independent dermatology groups of size that hasn’t already gained private equity backing, is exploring a sale, Buyouts has learned. The northern New England network of skin-treatment clinics is working with middle-market investment bank Browns Gibbons Lang, according to two sources familiar with the matter. Management meetings are getting […]
Bain & Company, Kara Murphy, private equity
Healthcare is poised to remain a safe-haven investment in 2017 as the sector’s long-term fundamentals remain positive, but the bar is rising as a growing number of funds disproportionately focus on the sector, according to Bain & Co Partner Kara Murphy. “The reality is [that] in a world where it’s so hard to get deals done, […]
Frontier Capital, Andrew Lindner, private equity
Employer-provided healthcare supports corporate wellness consolidation Frontier’s Viverae explores potential transactions PE firm eyes deals in RCM, cost-containment and tech supporting shift to value-based care Andrew Lindner is a co-founder and managing partner of Frontier Capital, where he helps lead the Charlotte, N.C., firm’s healthcare IT and vertical SaaS investment activities. Regardless of how the […]
For healthcare-focused private equity groups, specialization is more important than ever, panelists at ACG InterGrowth 2017 in Las Vegas emphasized this week. Opportunistically pursuing an asset at a below-market value is a strategy that no longer exists, especially as bulge-bracket firms increasingly compete for sub-$5-million EBITDA assets, said Enhanced Equity Funds principal Matthew Thompson on […]
American Securities, SpecialtyCare, medical services, healthcare, hospitals, private equity
SpecialtyCare, the American Securities-backed provider of intraoperative neuromonitoring and other emergency-room services, is in the midst of a sales process, according to four sources. Barclays is conducting the process, two sources said. The Nashville company generates about $55 million in EBITDA, two sources said. The target ought to fetch a multiple of roughly 10 times, […]
During Gores Group’s ownership of Fotona Holdings, the Slovenia medical-laser maker posted compound annual sales growth of about 23 percent while profitability nearly quadrupled, the firm’s managing director, Victor Otley, told Buyouts. Three-plus years after buying Fotona from the Slovenia government in a complex transaction, the firm unloaded its majority stake. The buyer is AGIC Capital, a Shanghai […]
ArroHealth, New Mountain Capital, SunTrust Robinson Humphrey
ArroHealth’s sale to New Mountain Capital’s CIOX Health commanded a $125 million to $130 million valuation, Buyouts has learned. New Mountain and CIOX Health on April 18 announced the acquisition of the provider of risk-adjustment services to health plans and providers, confirming an April 10 report by Buyouts. Terms weren’t disclosed. The deal follows a highly […]
In the latest in a slew of eye-care transactions, H.I.G. Capital on Monday said it acquired SouthWestern Eye and Barnet Dulaney Perkins to create a regional ophthalmology platform. The announcement confirms a Feb. 23 Buyouts report that the Miami firm was negotiating transactions for the pair of Arizona vision-treatment providers. SouthWestern was advised by Intrepid Investment […]
EnableComp LLC, a provider of workers’ compensation revenue-recovery services to the healthcare industry, is on the auction block, according to three sources. The Franklin, Tennessee, middle-market investment firm Brentwood Capital Advisors is advising the privately held company, Buyouts has learned. EnableComp generates $6 million to $8 million in EBITDA, one source estimated. A second source […]
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination